0001493152-19-013821.txt : 20191024 0001493152-19-013821.hdr.sgml : 20191024 20190906170010 ACCESSION NUMBER: 0001493152-19-013821 CONFORMED SUBMISSION TYPE: CORRESP PUBLIC DOCUMENT COUNT: 2 FILED AS OF DATE: 20190906 FILER: COMPANY DATA: COMPANY CONFORMED NAME: AIM ImmunoTech Inc. CENTRAL INDEX KEY: 0000946644 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 520845822 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: 2117 SW HIGHWAY 484 CITY: OCALA STATE: FL ZIP: 32801 BUSINESS PHONE: 352-448-7797 MAIL ADDRESS: STREET 1: 2117 SW HIGHWAY 484 CITY: OCALA STATE: FL ZIP: 32801 FORMER COMPANY: FORMER CONFORMED NAME: HEMISPHERX BIOPHARMA INC DATE OF NAME CHANGE: 19950614 CORRESP 1 filename1.htm

SILVERMAN SHIN & BYRNE PLLC

Wall Street Plaza

22nd Floor

88 Pine Street

NEW YORK, NY 10005

212.779.8600

Facsimile: 212.779.8858

New Jersey

19 Engle Street

Tenafly, NJ 07670

(201) 567-4969

September 6, 2019

Division of Corporation Finance

Securities and Exchange Commission

100 F Street, NE

Washington, DC 20549

	Re:	AIM ImmunoTech Inc. (formerly Hemispherx Biopharma, Inc.)
		Registration Statement on Form S-1

Dear Sir or Madam:

On behalf of AIM ImmunoTech Inc. we file herewith a registration statement on Form S-1.

Please direct any questions or comments to the undersigned, Richard Feiner, Esq., 646 822-1170 (rfeiner@silverfirm.com) or John Shin, Esq., 646 822-1165 (jshin@silverfirm.com).

	Very truly yours,

	/s/ Richard Feiner
	Richard Feiner

cc: AIM ImmunoTech Inc..

GRAPHIC 2 corresp_001.jpg begin 644 corresp_001.jpg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end